FDA to vet embryonic stem cells’ safety : Nature News
April 9, 2008
The FDA seems to be most concerned about the cells’ potential to cause tumours or to differentiate in dangerous ways, and whether the animal safety tests that have been carried out so far provide enough evidence to justify testing ES cells in people, according to FDA briefing documents seen by Nature. Another issue concerns how patients should be monitored for signs of problems. Members of the advisory committee have been asked not to speak to the press before the meeting. (Nature)
